180 related articles for article (PubMed ID: 35459869)
1. AGR2-induced cholesterol synthesis drives lovastatin resistance that is overcome by combination therapy with allicin.
Sheng N; Wang YQ; Wang CF; Jia MQ; Niu HM; Lu QQ; Wang YN; Feng D; Zheng XX; Yuan HQ
Acta Pharmacol Sin; 2022 Nov; 43(11):2905-2916. PubMed ID: 35459869
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d.
Davidson MH; Palmisano J; Wilson H; Liss C; Dicklin MR
Clin Ther; 2003 Nov; 25(11):2738-53. PubMed ID: 14693301
[TBL] [Abstract][Full Text] [Related]
3. Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models.
Krause BR; Newton RS
Atherosclerosis; 1995 Oct; 117(2):237-44. PubMed ID: 8801869
[TBL] [Abstract][Full Text] [Related]
4. Anterior gradient 2 increases long-chain fatty acid uptake via stabilizing FABP1 and facilitates lipid accumulation.
Wang Y; Jia M; Liang C; Sheng N; Wang X; Wang F; Luo Y; Jiang J; Cai L; Niu H; Zhu D; Nesa EU; Young CY; Yuan H
Int J Biol Sci; 2021; 17(3):834-847. PubMed ID: 33767592
[TBL] [Abstract][Full Text] [Related]
5. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
6. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia.
Weber C; Erl W; Weber KS; Weber PC
J Am Coll Cardiol; 1997 Nov; 30(5):1212-7. PubMed ID: 9350917
[TBL] [Abstract][Full Text] [Related]
7. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind comparison of cerivastatin and lovastatin for treatment of primary hypercholesterolemia.
Yu WC; Chen CH; Tsao HM; Ding YA
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Jun; 65(6):260-7. PubMed ID: 12201566
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of lovastatin in lowering cholesterol in African Americans with primary hypercholesterolemia.
Fong RL; Ward HJ
Am J Med; 1997 Apr; 102(4):387-91. PubMed ID: 9217621
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.
Gentile S; Turco S; Guarino G; Sasso CF; Amodio M; Magliano P; Salvatore T; Corigliano G; Agrusta M; De Simone G; Gaeta I; Oliviero B; Torella R
Diabetes Obes Metab; 2000 Dec; 2(6):355-62. PubMed ID: 11225965
[TBL] [Abstract][Full Text] [Related]
12. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].
Forti N; Ramires JA
Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203
[TBL] [Abstract][Full Text] [Related]
13. Naringin alters the cholesterol biosynthesis and antioxidant enzyme activities in LDL receptor-knockout mice under cholesterol fed condition.
Kim HJ; Oh GT; Park YB; Lee MK; Seo HJ; Choi MS
Life Sci; 2004 Feb; 74(13):1621-34. PubMed ID: 14738906
[TBL] [Abstract][Full Text] [Related]
14. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
Pearson TA; Denke MA; McBride PE; Battisti WP; Brady WE; Palmisano J
Mayo Clin Proc; 2005 May; 80(5):587-95. PubMed ID: 15887425
[TBL] [Abstract][Full Text] [Related]
15. Hypocholesterolemic activity of cornelian cherry (Cornus mas L.) fruits.
Hosseinpour F; Shomali T; Rafieian-Kopaei M
J Complement Integr Med; 2017 Jun; 14(4):. PubMed ID: 28731315
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a dietary portfolio diet of cholesterol-lowering foods and a statin on LDL particle size phenotype in hypercholesterolaemic participants.
Gigleux I; Jenkins DJ; Kendall CW; Marchie A; Faulkner DA; Wong JM; de Souza R; Emam A; Parker TL; Trautwein EA; Lapsley KG; Connelly PW; Lamarche B
Br J Nutr; 2007 Dec; 98(6):1229-36. PubMed ID: 17663803
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
Plans-Rubió P
Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391
[TBL] [Abstract][Full Text] [Related]
18. Which statin is most efficient for the treatment of hypercholesterolemia? A cost-effectiveness analysis.
Cobos A; Jovell AJ; García-Altés A; García-Closas R; Serra-Majem L
Clin Ther; 1999 Nov; 21(11):1924-36. PubMed ID: 10890264
[TBL] [Abstract][Full Text] [Related]
19. Effect of lovastatin on hypercholesterolemia in chronic renal failure.
Subang MC; Stewart-Phillips JL; Gagnon RF
Adv Perit Dial; 1992; 8():381-4. PubMed ID: 1361828
[TBL] [Abstract][Full Text] [Related]
20. Effects of rutin on lipid profile in hypercholesterolaemic rats.
Ziaee A; Zamansoltani F; Nassiri-Asl M; Abbasi E
Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):253-8. PubMed ID: 19175365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
